vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and HYSTER-YALE, INC. (HY). Click either name above to swap in a different company.

HYSTER-YALE, INC. is the larger business by last-quarter revenue ($923.2M vs $719.4M, roughly 1.3× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs -5.7%, a 78.9% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -13.5%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $32.9M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -6.5%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Hyster-Yale Materials Handling, Inc., through its wholly owned operating subsidiary, Hyster-Yale Group, Inc., designs, engineers, manufactures, sells and services a comprehensive line of lift trucks and aftermarket parts marketed globally primarily under the Hyster and Yale brand names. It was spun off from NACCO Industries in 2012, but had been running as a standalone company within NACCO since 2002.

DOC vs HY — Head-to-Head

Bigger by revenue
HY
HY
1.3× larger
HY
$923.2M
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+16.6% gap
DOC
3.1%
-13.5%
HY
Higher net margin
DOC
DOC
78.9% more per $
DOC
73.2%
-5.7%
HY
More free cash flow
DOC
DOC
$324.1M more FCF
DOC
$357.0M
$32.9M
HY
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-6.5%
HY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOC
DOC
HY
HY
Revenue
$719.4M
$923.2M
Net Profit
$114.0M
$-52.5M
Gross Margin
14.2%
Operating Margin
17.4%
-4.0%
Net Margin
73.2%
-5.7%
Revenue YoY
3.1%
-13.5%
Net Profit YoY
2406.4%
-609.7%
EPS (diluted)
$0.16
$-2.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
HY
HY
Q4 25
$719.4M
$923.2M
Q3 25
$705.9M
$979.1M
Q2 25
$694.3M
$956.6M
Q1 25
$702.9M
$910.4M
Q4 24
$698.0M
$1.1B
Q3 24
$700.4M
$1.0B
Q2 24
$695.5M
$1.2B
Q1 24
$606.6M
$1.1B
Net Profit
DOC
DOC
HY
HY
Q4 25
$114.0M
$-52.5M
Q3 25
$-117.1M
$-2.3M
Q2 25
$31.7M
$-13.9M
Q1 25
$42.8M
$8.6M
Q4 24
$4.5M
$10.3M
Q3 24
$85.9M
$17.2M
Q2 24
$146.0M
$63.3M
Q1 24
$6.7M
$51.5M
Gross Margin
DOC
DOC
HY
HY
Q4 25
14.2%
Q3 25
58.6%
15.9%
Q2 25
60.2%
17.6%
Q1 25
61.1%
19.5%
Q4 24
60.3%
19.4%
Q3 24
60.0%
19.0%
Q2 24
60.6%
22.2%
Q1 24
59.8%
22.3%
Operating Margin
DOC
DOC
HY
HY
Q4 25
17.4%
-4.0%
Q3 25
9.2%
0.2%
Q2 25
5.7%
-0.9%
Q1 25
7.7%
2.3%
Q4 24
-2.2%
3.0%
Q3 24
14.1%
3.3%
Q2 24
22.3%
8.2%
Q1 24
3.7%
7.9%
Net Margin
DOC
DOC
HY
HY
Q4 25
73.2%
-5.7%
Q3 25
-16.6%
-0.2%
Q2 25
4.6%
-1.5%
Q1 25
6.1%
0.9%
Q4 24
0.7%
1.0%
Q3 24
12.3%
1.7%
Q2 24
21.0%
5.4%
Q1 24
1.1%
4.9%
EPS (diluted)
DOC
DOC
HY
HY
Q4 25
$0.16
$-2.97
Q3 25
$-0.17
$-0.13
Q2 25
$0.05
$-0.79
Q1 25
$0.06
$0.48
Q4 24
$0.02
$0.57
Q3 24
$0.12
$0.97
Q2 24
$0.21
$3.58
Q1 24
$0.01
$2.93

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
HY
HY
Cash + ST InvestmentsLiquidity on hand
$467.5M
Total DebtLower is stronger
$9.8B
$251.9M
Stockholders' EquityBook value
$7.5B
$472.0M
Total Assets
$20.3B
$2.0B
Debt / EquityLower = less leverage
1.31×
0.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
HY
HY
Q4 25
$467.5M
Q3 25
$91.0M
Q2 25
$89.4M
Q1 25
$70.6M
Q4 24
$119.8M
Q3 24
$180.4M
Q2 24
$106.9M
Q1 24
$101.8M
Total Debt
DOC
DOC
HY
HY
Q4 25
$9.8B
$251.9M
Q3 25
$9.1B
$252.2M
Q2 25
$9.0B
$245.2M
Q1 25
$8.9B
$242.6M
Q4 24
$8.7B
$241.9M
Q3 24
$8.6B
$247.4M
Q2 24
$8.6B
$248.5M
Q1 24
$8.8B
$239.7M
Stockholders' Equity
DOC
DOC
HY
HY
Q4 25
$7.5B
$472.0M
Q3 25
$7.6B
$536.0M
Q2 25
$7.9B
$544.7M
Q1 25
$8.2B
$510.0M
Q4 24
$8.4B
$475.1M
Q3 24
$8.6B
$529.9M
Q2 24
$8.8B
$465.7M
Q1 24
$8.9B
$412.1M
Total Assets
DOC
DOC
HY
HY
Q4 25
$20.3B
$2.0B
Q3 25
$19.6B
$2.1B
Q2 25
$19.8B
$2.1B
Q1 25
$19.8B
$2.1B
Q4 24
$19.9B
$2.0B
Q3 24
$20.0B
$2.2B
Q2 24
$20.2B
$2.1B
Q1 24
$20.5B
$2.1B
Debt / Equity
DOC
DOC
HY
HY
Q4 25
1.31×
0.53×
Q3 25
1.20×
0.47×
Q2 25
1.14×
0.45×
Q1 25
1.08×
0.48×
Q4 24
1.04×
0.51×
Q3 24
1.00×
0.47×
Q2 24
0.98×
0.53×
Q1 24
0.99×
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
HY
HY
Operating Cash FlowLast quarter
$1.3B
$56.5M
Free Cash FlowOCF − Capex
$357.0M
$32.9M
FCF MarginFCF / Revenue
49.6%
3.6%
Capex IntensityCapex / Revenue
124.4%
2.6%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters
$23.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
HY
HY
Q4 25
$1.3B
$56.5M
Q3 25
$315.0M
$37.1M
Q2 25
$363.5M
$28.9M
Q1 25
$279.4M
$-36.4M
Q4 24
$1.1B
$80.7M
Q3 24
$318.2M
$70.1M
Q2 24
$316.2M
$-2.5M
Q1 24
$152.6M
$22.4M
Free Cash Flow
DOC
DOC
HY
HY
Q4 25
$357.0M
$32.9M
Q3 25
$22.6M
Q2 25
$15.1M
Q1 25
$-47.0M
Q4 24
$333.7M
$62.8M
Q3 24
$59.9M
Q2 24
$-14.7M
Q1 24
$14.9M
FCF Margin
DOC
DOC
HY
HY
Q4 25
49.6%
3.6%
Q3 25
2.3%
Q2 25
1.6%
Q1 25
-5.2%
Q4 24
47.8%
5.9%
Q3 24
5.9%
Q2 24
-1.3%
Q1 24
1.4%
Capex Intensity
DOC
DOC
HY
HY
Q4 25
124.4%
2.6%
Q3 25
1.5%
Q2 25
1.4%
Q1 25
1.2%
Q4 24
105.6%
1.7%
Q3 24
1.0%
Q2 24
1.0%
Q1 24
0.7%
Cash Conversion
DOC
DOC
HY
HY
Q4 25
10.99×
Q3 25
Q2 25
11.48×
Q1 25
6.52×
-4.23×
Q4 24
235.43×
7.83×
Q3 24
3.71×
4.08×
Q2 24
2.17×
-0.04×
Q1 24
22.85×
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOC
DOC

Segment breakdown not available.

HY
HY

Sales Channel Through Intermediary$281.7M31%
Aftermarketsales$179.1M19%
Sales Channel Directly To Consumer$173.6M19%
EMEAHY$153.3M17%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$89.0M10%
Otherrevenue$42.4M5%

Related Comparisons